Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Epizyme Inc. EPZM

Epizyme Inc is a clinical-stage biopharmaceutical company that is committed to rewriting treatment for cancer and other serious diseases through discovering, developing, and commercializing novel epigenetic medicines. Its product candidates include one approved product, TAZVERIK (tazemetostat), an inhibitor of the EZH2. The company is also developing additional programs, such as pinometostat, an intravenously administered small molecule inhibitor of DOT1L for the treatment of acute leukemias and PRMT5 inhibitor.

The Power Play by The Market Herald
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Stock Price Chart (NDAQ:EPZM)

Fundamentals Snapshot (NDAQ:EPZM)

Current News (NDAQ:EPZM)

Epizyme Reports Second Quarter 2022 Financial Results and Provides Business Update

Business Wire 8 days ago

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates ONEM, EPZM, LION

PR Newswire July 26, 2022

SHAREHOLDER ALERT: Weiss Law Reminds WWE, DRE, MN, and EPZM Shareholders About Its Ongoing Investigations

PR Newswire July 25, 2022

Shareholder Alert - The M&A Class Action Firm Continues Investigating the Merger - FSTX, EPZM, STCN, SIMO, VMW, VHAQ

PR Newswire July 16, 2022

SHAREHOLDER ALERT: Weiss Law Reminds RFP, ZEN, RDUS, and EPZM Shareholders About Its Ongoing Investigations

PR Newswire July 14, 2022

EPIZYME INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Epizyme, Inc. - EPZM

Business Wire July 12, 2022

SHAREHOLDER ALERT: Weiss Law Reminds FSTX, ZEN, RDUS, and EPZM Shareholders About Its Ongoing Investigations

PR Newswire July 6, 2022

Moore Kuehn Encourages EPZM, RDUS, OBCI, and CNVY Investors to Contact Law Firm

PR Newswire July 6, 2022

INVESTIGATION NOTICE: Halper Sadeh LLP Investigates ZEN, USAK, EPZM

PR Newswire July 5, 2022

Bullboard Posts (NDAQ:EPZM)

Thanks for the tip Jack, just sold with A great profit

these are easy to pick when you get help
armordeck - June 27, 2022

The potential remains strong

FDA approved this cancer medicine and the stock went down considerably while investors and traders were expecting a huge gain. Anyone...
Happy-Nest - January 25, 2020